Roivant Sciences Ltd. — Director's Dealing 2025

Dec 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-12-16

Reporting Person: Gold Daniel Allen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-16	Common Shares	S	275000	$22.93	Disposed	17772727	Indirect
2025-12-16	Common Shares	S	642282	$23.08	Disposed	17130445	Indirect
2025-12-17	Common Shares	S	432718	$23.05	Disposed	16697727	Indirect
2025-12-17	Common Shares	S	155076	$23.02	Disposed	16542651	Indirect
2025-12-17	Common Shares	S	189538	$23.17	Disposed	16353113	Indirect

Footnotes

F1: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.